244 related articles for article (PubMed ID: 8275900)
1. [Pharmacologic treatment of obsessive compulsive disorder in the child and adolescent].
Flament MF
Encephale; 1993; 19(2):75-81. PubMed ID: 8275900
[TBL] [Abstract][Full Text] [Related]
2. [Critical analysis of controlled pharmacologic studies in obsessive compulsive disorder].
Brochier T; Hantouche E
Encephale; 1989; 15(3):325-33. PubMed ID: 8641159
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic therapy of obsessive compulsive disorder.
DeVeaugh-Geiss J
Adv Pharmacol; 1994; 30():35-52. PubMed ID: 7833296
[TBL] [Abstract][Full Text] [Related]
4. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
Pigott TA; Seay SM
J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
Piccinelli M; Pini S; Bellantuono C; Wilkinson G
Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
[TBL] [Abstract][Full Text] [Related]
6. New pharmacologic approaches to obsessive compulsive disorder.
Insel TR
J Clin Psychiatry; 1990 Oct; 51 Suppl():47-51; discussion 56-8. PubMed ID: 2120204
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic management of obsessive-compulsive disorder.
Jackson CW; Morton WA; Lydiard RB
South Med J; 1994 Mar; 87(3):310-21. PubMed ID: 8134850
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of childhood obsessive-compulsive disorder.
Leonard HL; Rapoport JL
Psychiatr Clin North Am; 1989 Dec; 12(4):963-70. PubMed ID: 2690035
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.
Flament MF; Bisserbe JC
J Clin Psychiatry; 1997; 58 Suppl 12():18-22. PubMed ID: 9393392
[TBL] [Abstract][Full Text] [Related]
10. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
Varigonda AL; Jakubovski E; Bloch MH
J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
[TBL] [Abstract][Full Text] [Related]
11. A review of pharmacologic treatments for obsessive-compulsive disorder.
Kaplan A; Hollander E
Psychiatr Serv; 2003 Aug; 54(8):1111-8. PubMed ID: 12883138
[TBL] [Abstract][Full Text] [Related]
12. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators.
Zohar J; Judge R
Br J Psychiatry; 1996 Oct; 169(4):468-74. PubMed ID: 8894198
[TBL] [Abstract][Full Text] [Related]
13. Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents.
Figueroa Y; Rosenberg DR; Birmaher B; Keshavan MS
J Child Adolesc Psychopharmacol; 1998; 8(1):61-7. PubMed ID: 9639080
[TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder.
López-Ibor JJ; Saiz J; Cottraux J; Note I; Viñas R; Bourgeois M; Hernández M; Gómez-Pérez JC
Eur Neuropsychopharmacol; 1996 May; 6(2):111-8. PubMed ID: 8791036
[TBL] [Abstract][Full Text] [Related]
15. On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
Todorov C; Freeston MH; Borgeat F
Can J Psychiatry; 2000 Apr; 45(3):257-62. PubMed ID: 10779882
[TBL] [Abstract][Full Text] [Related]
16. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
[TBL] [Abstract][Full Text] [Related]
17. Age onset subtypes of obsessive compulsive disorder: differences in clinical response to treatment with clomipramine.
Ulloa RE; Nicolini H; Avila M; Fernández-Guasti A
J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):85-96. PubMed ID: 17343556
[TBL] [Abstract][Full Text] [Related]
18. A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Carpenter LL; McDougle CJ; Epperson CN; Price LH
Drug Saf; 1996 Aug; 15(2):116-34. PubMed ID: 8884163
[TBL] [Abstract][Full Text] [Related]
19. Obsessive-compulsive disorder: a new perspective in diagnosis and treatment.
Lydiard RB
Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():33-7. PubMed ID: 7963449
[TBL] [Abstract][Full Text] [Related]
20. [Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system].
Baving L; Schmidt MH
Z Kinder Jugendpsychiatr Psychother; 2000 Feb; 28(1):35-44. PubMed ID: 10746297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]